Skip to main content

Table 2 Cytokine levels in plasma

From: Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response

   

CpG-ODN

 

PBS

Control ODN

6

24

48

168 (h)

IL-1β

34.7 ± 6.3

28.8 ± 6.6

47.6 ± 14.9

56.6 ± 5.6*†

42.4 ± 6.0*†

25.0 ± 4.4

IL-10

39.0 ± 0.6

33.5 ± 4.1

35.6 ± 13.0

95.2 ± 17.0

122.3 ± 18.5*†

46.1 ± 16.8

IFN-γ

2.3 ± 1.0

10.6 ± 4.3

1.7 ± 0.6

12.5 ± 4.8

4.2 ± 1.8

8.3 ± 7.5

TNF-α

759.0 ± 96.8

664.2 ± 78.0

550.3 ± 64.8

777.7 ± 83.0

690.8 ± 135.8

633.2 ± 74.0

IL-6

29.3 ± 18.8

14.1 ± 2.2

39.0 ± 7.0

124.3 ± 17.6*†

46.2 ± 9.3

12.7 ± 6.2

IL-12p40

126.0 ± 4.8

116.4 ± 10.9

314.5 ± 65.8*†

303.9 ± 20.9*†

235.8 ± 30.2

120.2 ± 12.4

KC

31.9 ± 4.9

32.0 ± 4.1

53.1 ± 13.4

92.7 ± 12.4*†

47.8 ± 9.8

23.2 ± 3.7

MCP-1

16.0 ± 5.7

4.6 ± 3.9

48.2 ± 27.0

137.1 ± 41.5*†

25.9 ± 9.5

13.6 ± 3.5

MIP-1α

31.5 ± 4.4

29.2 ± 3.4

25.5 ± 7.6

65.0 ± 8.9

42.0 ± 7.2

21.3 ± 11.2

MIP-1β

8.5 ± 2.5

6.3 ± 3.4

8.4 ± 3.4

23.6 ± 4.4†

10.7 ± 2.8

2.7 ± 1.3

  1. All values (pg/mL) are expressed as the means ± SE (n = 5-6 in each group). *p < 0.05 was considered to be significantly different from the corresponding value of the PBS group. † p < 0.05 was considered to be significantly different from the corresponding value of the control ODN group.